Real-world community oncology-based treatment patterns for first line axitinib plus pembrolizumab in advanced renal cell carcinoma: Initial dosing, dose reductions and clinical outcomes Meeting Abstract
| Authors: | Zarrabi, K. K.; Ababio, Y.; Eccleston, A.; Rao, Drnj; Kelly, S.; Chang, J. E.; Adejumo, K. L.; Lucht, S.; Paydar, C.; Van Doren, B. A.; Bland, E.; John, W. S.; Feinberg, B. A.; Shah, N. J. |
| Abstract Title: | Real-world community oncology-based treatment patterns for first line axitinib plus pembrolizumab in advanced renal cell carcinoma: Initial dosing, dose reductions and clinical outcomes |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-01 |
| Language: | English |
| ACCESSION: | WOS:001454741800032 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.487 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 487 -- Source: Wos |
